Biotech · Private company · Agoura Hills, CA, US

ACELYRIN, Inc.

SEC CIK 0001962918

Track this companyFree. Adds ACELYRIN, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials60 recruiting or active

Pipeline programs5From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline5

Hidradenitis Suppurativa Study of IzokibepPHASE3 · TERMINATED · started Jun 22, 2023ClinicalTrials.gov NCT05905783 · fetched Nov 12, 2026
Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED)PHASE1_PHASE2 · COMPLETED · started Feb 14, 2023ClinicalTrials.gov NCT05683496 · fetched Nov 12, 2026
Psoriatic Arthritis Study of IzokibepPHASE2_PHASE3 · TERMINATED · started Nov 21, 2022ClinicalTrials.gov NCT05623345 · fetched Nov 12, 2026
Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitisPHASE2 · TERMINATED · started Aug 23, 2022ClinicalTrials.gov NCT05384249 · fetched Nov 12, 2026
Hidradenitis Suppurativa Phase 2b Study of IzokibepPHASE2 · COMPLETED · started May 5, 2022ClinicalTrials.gov NCT05355805 · fetched Nov 12, 2026
A Trial of the Efficacy and Safety of Izokibep in the Treatment of Non-anterior UveitisPHASE2 · COMPLETED · started Jan 6, 2022ClinicalTrials.gov NCT04706741 · fetched Nov 12, 2026